Global Glioma Market Growth Driven by Therapeutic Innovations and Aging Population [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
Glioblastoma Multiforme (GBM) is the deadliest type, characterized by rapid growth and invasiveness. Early diagnosis and treatment are crucial for improving patient outcomes. The market is driven by rising glioma cases, advancing cancer therapies, and enhanced diagnostic tools. Challenges include drug resistance, high treatment costs, and complex regulatory issues. Leading companies like Merck & Co., Amgen, and Pfizer are enhancing chemotherapy and immunotherapy strategies. Market growth is supported by innovations in drug delivery systems and increasing clinical awareness. Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Glioma Market - A Global and Regional Analysis: Focus on Disease Type, End-user, Country, and Region, 2025-2035" has been added to ResearchAndMarkets.com's offering. The Global Glioma Market focuses on the pharmacological and therapeutic management of gliomas, a group of aggressive and fast-growing brain tumors arising from glial cells. Glioblastoma Multiforme (GBM
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Reed Jobs Lost His Father Steve To Cancer. Now His Cancer VC Firm Has Raised $200 Million. [Forbes]Forbes
- ISS National Lab Marks Record Year for Space-Based Scientific Results [Yahoo! Finance]Yahoo! Finance
- Curious about Merck (MRK) Q4 Performance? Explore Wall Street Estimates for Key Metrics [Yahoo! Finance]Yahoo! Finance
- This Stock Is Already Up 58% This Year. Is It a Buy? [Yahoo! Finance]Yahoo! Finance
- What's Fueling The Rally In Merck Stock? [Forbes]Forbes
MRK
Earnings
- 10/30/25 - Beat
MRK
Sec Filings
- 1/28/26 - Form 4
- 1/28/26 - Form 4
- 1/28/26 - Form 4
- MRK's page on the SEC website